Circulating Biomarkers of Cardiopulmonary Disturbances in COVID-19

Pp: 99-112 (14)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Significant findings have been obtained on the relationship between underlying cardiovascular disease and the severity of COVID-19 infection. Using plasma profiles of patients with COVID-19, biomarkers in circulation were also identified that varied depending on the patient's characteristics and disease. The purpose of this study is to review the sources that focus on circulating biomarkers of cardiopulmonary disorders. In addition to conventional biomarkers such as troponin, we consider data from new emerging biomarkers about their roles in the prognosis of severity, mortality in the hospital and effectiveness of treatment. Consideration of mechanisms associated with circulating biomarkers in various conditions associated with COVID-19 can provide broader tools for the diagnosis, treatment, and prognosis of at-risk patients

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books